Drugs & Targets FDA approves Amgen and Allergan’s Kanjinti, Herceptin biosimilar June 21, 2019Vol.45 No.25
Drugs & Targets Myriad receives second insurance reimbursement decision for its BRACAnalysis in Japan June 21, 2019Vol.45 No.25
Drugs & Targets Gilead, Nurix form collaboration to develop cancer therapies June 21, 2019Vol.45 No.25
Drugs & TargetsFree FDA approves chemoimmunotherapy regimen in diffuse large B-cell lymphoma June 14, 2019Vol.45 No.24
Drugs & Targets FDA grants Priority Review for daratumumab combination in multiple myeloma June 07, 2019Vol.45 No.23
